Thomais Markou
AstraZeneca (Australia)(AU)Imperial College London(GB)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Protein Kinase Regulation and GTPase Signaling, Cardiac Fibrosis and Remodeling, Cardiac Ischemia and Reperfusion, Asthma and respiratory diseases
Most-Cited Works
- → Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the Wireless Stimulation Endocardially for CRT (WiSE-CRT) study(2014)193 cited
- → Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses(2007)161 cited
- → Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension(2020)95 cited
- → First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients(2013)94 cited
- → Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways(2004)70 cited
- → Glycogen synthase kinases 3α and 3β in cardiac myocytes: Regulation and consequences of their inhibition(2007)